# A Study of Efficacy and Safety of Qutenza in Patients With Post-operative Peripheral Neuropathic Pain

> **NCT02171182** · — · COMPLETED · sponsor: **Astellas Pharma s.r.o.** · enrollment: 319 (actual)

## Conditions studied

- Post-operative Peripheral Neuropathic Pain

## Interventions

- **DRUG:** Qutenza

## Key facts

- **NCT ID:** NCT02171182
- **Lead sponsor:** Astellas Pharma s.r.o.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 319 (ACTUAL)
- **Last updated:** 2016-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02171182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02171182, "A Study of Efficacy and Safety of Qutenza in Patients With Post-operative Peripheral Neuropathic Pain". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT02171182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*